Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 22;7(3):503-512.
doi: 10.1039/c8tx00030a. eCollection 2018 May 8.

The subchronic exposure to malathion, an organophosphate pesticide, causes lipid peroxidation, oxidative stress, and tissue damage in rats: the protective role of resveratrol

Affiliations

The subchronic exposure to malathion, an organophosphate pesticide, causes lipid peroxidation, oxidative stress, and tissue damage in rats: the protective role of resveratrol

Erten Akbel et al. Toxicol Res (Camb). .

Abstract

The present study was planned to evaluate the protective role of resveratrol (Res) against subchronic malathion exposure in rats over four weeks. In total, 48 Wistar rats were used and divided equally into six groups. The groups were designed as the control group (received only a rodent diet and tap water), the corn oil group (0.5 ml corn oil by the oral route), and the malathion group (100 mg kg-1 day-1 by the oral route). Other three groups received malathion (100 mg kg-1 day-1) plus Res (5, 10, and 20 mg kg-1 day-1, respectively) by the oral route. Malathion increased malondialdehyde and 8-OHdG levels, whereas it decreased glutathione levels. Also, acetylcholinesterase, superoxide dismutase, and catalase activities were found to be low in the blood, liver, kidney, heart, and brain tissues. Biochemical parameters were not notably changed in all groups. In contrast, Res treatment inverted malathion-induced oxidative stress, lipid peroxidation, and activity of enzymes. Additionally, malathion-induced histopathological changes in the liver, kidney, heart, and brain were ameliorated by Res treatment. These results demonstrate that malathion increases oxidative stress and decreases the antioxidant status while Res has a protective function against malathion toxicity in rats.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Malaoxon levels in the plasma (A), liver (B), kidney (C), heart (D), and brain (E) of rats treated with malathion at a dose of 100 mg kg–1 day–1, orally. Values are expressed as the mean ± SD of 8 samples per group. Statistical significance: *p < 0.05, ** p < 0.01, ***p < 0.001 versus the control group.
Fig. 2
Fig. 2. 8-OHdG (A) and AchE activity (B) levels in serum of rats treated with malathion at a dose of 100 mg kg–1 day–1, orally. Values are expressed as the mean ± SD of 8 samples per group. Statistical significance: *p < 0.05 versus the malathion group.
Fig. 3
Fig. 3. The effect of resveratrol (Res) on malathion induced damage in the brain (A), heart (B), liver (C), and kidney (D) of rats. Representative figures were stained with H&E. The original magnification was ×20 and the scale bars represent 100 μm. Arrows and arrow heads indicate focal gliosis and neuronal degenerations in the brain (A3), hyaline degenerations in the heart (B3), sinusoidal dilatation and degenerations of hepatocytes in the liver (C3), and degenerations in the tubule and shrinkage of Bowman's capsule in the kidney (D3) of rats, respectively. (1) The control group, (2) the corn oil group, (3) animals treated with 100 mg kg–1 day–1 malathion, (4) animals treated with 5 mg kg–1 day–1 Res and 100 mg kg–1 day–1 malathion, (5) animals treated with 10 mg kg–1 day–1 Res and 100 mg kg–1 day–1 malathion, and (6) animals treated with 20 mg kg–1 day–1 Res and 100 mg kg–1 day–1 malathion.

References

    1. El-Demerdash F. M., Nasr H. M. J. Trace Elem. Med. Biol. 2014;28:89–93. - PubMed
    1. Gupta V. K., Sharma B. Anatomy Physiol. Biochem. Int. J. 2016;1:555558.
    1. Suresh B. N., Malik J. K., Rao G. S., Aggarwal M., Ranganathan V. Environ. Toxicol. Pharmacol. 2006;22:167–171. - PubMed
    1. Ince S., Arslan-Acaroz D., Demirel H. H., Varol N., Ozyurek H. A., Zemheri F., Eryavuz A. Biomed Pharmacother. 2017;96:263–268. - PubMed
    1. El-Demerdash F. M. Food Chem. Toxicol. 2011;49:1346–1352. - PubMed